Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DOLBY LABORATORIES, INC.

(DLB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization1 7 1576 3746 5389 102--
Entreprise Value (EV)1 6 0535 4495 4117 7777 6707 521
P/E ratio 60,6x25,9x28,9x30,9x29,3x25,8x
Yield 0,97%1,25%1,35%0,98%1,16%1,16%
Capitalization / Revenue 6,11x5,13x5,63x7,02x6,52x6,24x
EV / Revenue 5,17x4,39x4,66x6,00x5,49x5,15x
EV / EBITDA 13,4x12,0x13,7x14,4x13,3x11,8x
Price to Book 3,36x2,86x2,68x3,59x3,39x3,15x
Nbr of stocks (in thousands) 103 647100 770100 595101 387--
Reference price (USD) 69,163,365,089,889,889,8
Announcement Date 10/24/201811/14/201911/12/2020---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales1 1 1721 2421 1621 2961 3971 459
EBITDA1 453455394541576640
Operating profit (EBIT)1 300257219401443478
Operating Margin 25,6%20,7%18,8%31,0%31,7%32,8%
Pre-Tax Profit (EBT)1 313282240391431487
Net income1 122255231301312353
Net margin 10,4%20,5%19,9%23,2%22,4%24,2%
EPS2 1,142,442,252,913,063,48
Dividend per Share2 0,670,790,880,881,041,04
Announcement Date 10/24/201811/14/201911/12/2020---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: September 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 390320287300394361
EBITDA1 22313410494,1198124
Operating profit (EBIT)1 16583,256,157,3142105
Operating Margin 42,3%26,0%19,6%19,1%36,0%29,1%
Pre-Tax Profit (EBT)1 16785,459,143,9126107
Net income1 13576,254,635,410085,7
Net margin 34,7%23,9%19,0%11,8%25,4%23,7%
EPS2 1,300,730,520,351,040,76
Dividend per Share ------
Announcement Date 01/28/202105/04/202107/29/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 1 1039251 1271 3251 4321 580
Leverage (Debt / EBITDA) -2,44x-2,03x-2,86x-2,45x-2,49x-2,47x
Free Cash Flow1 279231278419414453
ROE (Net Profit / Equities) 14,5%14,3%9,76%15,0%15,2%15,8%
Shareholders' equity1 8441 7812 3702 0082 0592 234
ROA (Net Profit / Asset) 12,1%11,8%8,06%12,6%12,8%13,5%
Assets1 1 0132 1682 8702 3992 4422 622
Book Value Per Share2 20,522,124,325,026,528,5
Cash Flow per Share ------
Capex1 72,896,366,360,095,0101
Capex / Sales 6,21%7,75%5,71%4,63%6,80%6,92%
Announcement Date 10/24/201811/14/201911/12/2020---
1 USD in Million
2 USD
Key data
Capitalization (USD) 9 101 553 720
Net sales (USD) 1 161 792 000
Number of employees 2 289
Sales / Employee (USD) 507 554
Free-Float 63,1%
Free-Float capitalization (USD) 5 742 124 943
Avg. Exchange 20 sessions (USD) 35 966 297
Average Daily Capital Traded 0,40%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA